CCOPS Unhappy With NCI Policy Limiting Their Participation In Early Phase 2 Clinical Trials
In Brief: Oldham to Leave NCI, Herberman Acting Head Of BRMP; Lansky Appointed Director Of ICC
Cooperative Groups Not Included Among Grants to Be Funded At Recommended Levels
“Withheld” News Release On QRA Policies Released
CCRU, CCSP Projects Described; Plans Listed for DRCCA Applications Branch
DRCCA Board Oks Noncompetitive Contract Concepts
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State
- Breast cancer activists in the 90s got DOD to fund cancer research—now that program has been gutted
- In The Headlines: HHS shakeup threatens a legacy of medical breakthroughs